Frederick Larcombe

Frederick Larcombe

67 year
Health Technology
Retail Trade
Commercial Services

Profile

Mr. Fred Larcombe, CPA, is a Principal at Crimson Partners, Chief Financial Officer at iBIO, Chief Financial Officer, Secretary & Director at Heartland Bridge Capital, Inc., Chief Financial Officer at The Riderwood Group, Inc., and Chief Financial Officer at Heartland Bridge Capital, Inc. (Private Equity).
Mr. Larcombe has served as Chief Financial Officer for: Xenomics, a developer of DNA diagnostic tests; FermaVir Pharmaceuticals, a pharmaceutical development company; MicroDose Technologies, a drug delivery device company; and Genesis Direct, an internet retailer.
He started his professional career with PriceWaterhouseCoopers (PwC).
Mr. Larcombe received his BS in Accounting from Seton Hall University, and is a graduate of the Management Development Program at Harvard Business School.

Frederick Larcombe active positions

Former positions of Frederick Larcombe

CompaniesPositionEnd
TRIR WELL Director of Finance/CFO 2012-10-24
IBIO, INC. Director of Finance/CFO 2011-05-02
See the detail of Frederick Larcombe's experience

Training of Frederick Larcombe

Seton Hall University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Frederick Larcombe's experience

Connections

28

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
CARDIFF ONCOLOGY, INC.

Health Technology

IBIO, INC.

Health Technology

TRIR WELL

Health Technology

Private companies4

Retail Trade

Commercial Services

Health Technology

Electronic Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Frederick Larcombe